Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
72.47
-1.63 (-2.20%)
At close: Jul 25, 2025, 2:57 PM CST

SHA:688192 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
33,29417,23719,53016,03014,959-
Upgrade
Market Cap Growth
9.44%-11.74%21.83%7.16%--
Upgrade
Enterprise Value
33,83017,34218,89114,51814,805-
Upgrade
Last Close Price
72.4741.4747.8539.3737.01-
Upgrade
PS Ratio
75.9747.89213.94-1454.37-
Upgrade
PB Ratio
1414.7086.1623.019.126.07-
Upgrade
P/TBV Ratio
--50.5112.667.53-
Upgrade
EV/Sales Ratio
77.2048.18206.94-1439.37-
Upgrade
Debt / Equity Ratio
60.775.790.480.050.04-
Upgrade
Asset Turnover
0.260.220.05-0.010.03
Upgrade
Inventory Turnover
0.480.350.54---
Upgrade
Quick Ratio
1.061.111.785.709.825.88
Upgrade
Current Ratio
1.141.272.035.939.966.06
Upgrade
Return on Equity (ROE)
-252.50%-179.21%-84.98%-34.87%-37.83%-76.72%
Upgrade
Return on Assets (ROA)
-34.80%-37.70%-40.35%-20.52%-21.46%-52.76%
Upgrade
Return on Capital (ROIC)
-42.74%-46.33%-46.54%-22.54%-23.23%-62.42%
Upgrade
Earnings Yield
-2.45%-4.91%-5.67%-4.59%-4.48%-
Upgrade
FCF Yield
-2.56%-4.57%-5.12%-4.22%-3.35%-
Upgrade
Buyback Yield / Dilution
-1.45%-1.83%-0.70%-12.29%-0.07%-
Upgrade
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.